GMED
Globus Medical, Inc.
Medical Devices · Healthcare · United States
82.91
close · 2026-10-29
value
66
cheaper than peers66
quality
99
stronger fundamentals99
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 15.38× | 80 |
| EV to EBITDA | 11.10× | 72 |
| price to book | 2.33× | 61 |
| price to sales | 3.61× | 38 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 2.5% | 94 |
| operating margin | 21.3% | 93 |
| revenue growth | 27.0% | 87 |
| return on equity | 13.3% | 85 |
4 of 4 measures available
Facts
| market cap | $11B |
| free cash flow | $341.1M |
| employees | 6,000 |
| first trade | 2012-08-03 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 3.92 | 0.75 | 1.07 | 1.85 |
| free cash flow | $579.0M | $405.2M | $165.2M | $104.4M |
| net income | $537.9M | $103.0M | $122.9M | $190.2M |
| revenue | $2.94B | $2.52B | $1.57B | $1.02B |
| unusual items | $57.3M | -$96.7M | -$54.0M | -$9.3M |